Kindred Healthcare (NYSE: KND) is expected to report Q2 earnings around July 31. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Kindred Healthcare's revenue will grow 22.2% and EPS will contract 30.2%.

The average estimate for revenue is $1.58 billion. On the bottom line, the average EPS estimate is $0.37.

Revenue details
Last quarter, Kindred Healthcare booked revenue of $1.58 billion. GAAP reported sales were 33% higher than the prior-year quarter's $1.19 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.40. GAAP EPS of $0.35 for Q1 were 36% lower than the prior-year quarter's $0.55 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 33.3%, 220 basis points worse than the prior-year quarter. Operating margin was 3.8%, 10 basis points better than the prior-year quarter. Net margin was 1.2%, 70 basis points worse than the prior-year quarter.

Looking ahead
The full year's average estimate for revenue is $6.32 billion. The average EPS estimate is $1.48.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 131 members out of 142 rating the stock outperform, and 11 members rating it underperform. Among 41 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 39 give Kindred Healthcare a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kindred Healthcare is outperform, with an average price target of $11.43.